/DKSC

DKSC Stock - Dakshidin Corporation, Inc.

Q: What is the analyst price target for DKSC?

Analyst price target information is not currently available for DKSC.

Q: What is DKSC's market cap?

Market capitalization information is not currently available for DKSC.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00-33.33%

$0.00 (-33.33%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DKSC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-1.23

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	N/A	N/A	$2,480	$208,252	$19,067
Gross Profit	N/A	N/A	$2,480	$42,402	$19,067
Gross Margin	N/A	N/A	100.0%	20.4%	100.0%
Operating Income	$-17,720	$-167,090	$-216,840	$-7,880	$-183,400
Net Income	$-17,720	$-167,091	$-216,837	$-7,882	$-183,396
Net Margin	N/A	N/A	-8743.4%	-3.8%	-961.9%
EPS	$0.00	$-0.00	$-0.00	$0.00	$-0.00

Company Overview

Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.

Visit Website

Frequently Asked Questions about DKSC

What is DKSC's current stock price?

Dakshidin Corporation, Inc. (DKSC) is currently trading at $0.00 per share. The stock has moved -33.33% today.

What is the analyst price target for DKSC?

No analyst price targets are currently available for this stock.

What sector is Dakshidin Corporation, Inc. in?

Dakshidin Corporation, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is DKSC's market cap?

Dakshidin Corporation, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does DKSC pay dividends?

No, Dakshidin Corporation, Inc. does not currently pay a dividend to shareholders.